| Literature DB >> 35213952 |
Sanaz Behtaj1,2, Jenny A K Ekberg1,2,3, James A St John1,2,3.
Abstract
Injuries to the peripheral nervous system result in devastating consequences with loss of motor and sensory function and lifelong impairments. Current treatments have largely relied on surgical procedures, including nerve autografts to repair damaged nerves. Despite improvements to the surgical procedures over the years, the clinical success of nerve autografts is limited by fundamental issues, such as low functionality and mismatching between the damaged and donor nerves. While peripheral nerves can regenerate to some extent, the resultant outcomes are often disappointing, particularly for serious injuries, and the ongoing loss of function due to poor nerve regeneration is a serious public health problem worldwide. Thus, a successful therapeutic modality to bring functional recovery is urgently needed. With advances in three-dimensional cell culturing, nerve guidance conduits (NGCs) have emerged as a promising strategy for improving functional outcomes. Therefore, they offer a potential therapeutic alternative to nerve autografts. NGCs are tubular biostructures to bridge nerve injury sites via orienting axonal growth in an organized fashion as well as supplying a supportively appropriate microenvironment. Comprehensive NGC creation requires fundamental considerations of various aspects, including structure design, extracellular matrix components and cell composition. With these considerations, the production of an NGC that mimics the endogenous extracellular matrix structure can enhance neuron-NGC interactions and thereby promote regeneration and restoration of function in the target area. The use of electrospun fibrous substrates has a high potential to replicate the native extracellular matrix structure. With recent advances in electrospinning, it is now possible to generate numerous different biomimetic features within the NGCs. This review explores the use of electrospinning for the regeneration of the nervous system and discusses the main requirements, challenges and advances in developing and applying the electrospun NGC in the clinical practice of nerve injuries.Entities:
Keywords: extracellular matrix; fibrous scaffold; neural tissue engineering; peripheral nervous system; physical lumen filler; scaffold topography; structural support
Year: 2022 PMID: 35213952 PMCID: PMC8876219 DOI: 10.3390/pharmaceutics14020219
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Electrospinning set-up diagram, electrospun nanofibres and different variables in electrospinning process.
Recent studies focusing on the use of electrospun nerve conduits for regenerating peripheral nerves.
| Biomaterial | Cells | ES Parameters | Stimulating Agents | Stimulating Patterns | In Vivo | Refs. | ||
|---|---|---|---|---|---|---|---|---|
| Voltage (kV) | Flow Rate (mL·h−1) | Distance (cm) | ||||||
| chitosan | Schwann cells | 4 | 3 | - | BDNF & VEGF | aligned fibres | sciatic nerve defects in rats | [ |
| PLA/PPy | rat hippocampal progenitor | 15 | - | 10 | PPy-coating | external stimulus (200 mV/cm) | - | [ |
| PCL/chitosan | Schwann cells, PC12 cells and dorsal root ganglia | 15 | 1.5 | - | - | aligned fibres | sciatic nerve in adult female Sprague–Dawley rats | [ |
| PLCL | murine macrophage cell line and rat Schwann cells | 16 | 2 | 10 | - | oriented microfiber-bundle cores and randomly organized nanofiber in wall of NGC | rat sciatic nerve injury | [ |
| PCL | Schwann cells | 14 | 0.2 | - | sodium alginate hydrogel covalently cross-linked with N,N′-disuccinimidyl carbonate (DSC) | bilayer cylindrical conduit | sciatic nerves in a rat model | [ |
| polyvinyl alcohol (PVA)/carbon nanotubes (CNT) | fibroblasts | 19 and 21 | 0.06–0.08 | 10 | - | providing conductivity via CNT | - | [ |
| poly (lactide-co-trimethylene carbonate) (PLATMC) | Schwann cells | - | - | - | - | shape memory nanofibers | rat sciatic nerve defects | [ |
| poly (L/D-lactic acid) (PLDLA) and phosphate glass microfibers (PGFs) | dorsal root ganglion | 1.5 kV cm−1 | 0.1 mL min–1 | - | CNTs chemically attached on the surface of the NGC | - | transected rat sciatic nerve | [ |
| PCL | bone marrow stem cells (BMSCs) | 12 | 1 | - | - | honeycomb structure | - | [ |
| PLLA | dorsal root ganglion | 15 | 1 | 10 | porcine decellularized nerve matrix hydrogel | aligned fibres | rat sciatic nerve defect model | [ |
| PCL | PC-12 | 11 | 0.25 | 5.5 | cross-linking laminin | aligned fibres | rat sciatic nerve gap | [ |
| poly (lactic-co-glycolic acid) (PLGA) | - | 10 | 0.4 | 15 | collagen sponge | intraluminal sponge fillers | rat sciatic nerve | [ |
| poly (L-lactic acid)-co-poly(€-caprolactone), collagen (COL), polyaniline (PANI) | adipose-derived stem cells (ASCs) | 15 | 1 | 8 | - | - | rat model | [ |
| PCL/collagen VI | macrophages | 15 | 4 | 18 | sustained release of collagen VI | - | rat sciatic nerve | [ |
| chitosan | Schwann cell | 15 | 1 | 10 | - | - | - | [ |
| PVA/gelatin/gellan | neural cells | 19 | 0.8 | 15 | quercetin | patterned hybrid of aligned fibres scaffold | - | [ |
Figure 2The schematics of PNS damage, NGC, and various physical lumen fillers (PLFs). The nanofibers loaded with the appropriate combination of PLFs facilitate cell regeneration.
Figure 3(a) SEM images of aligned fibrous scaffolds (scale bar: 10 µm); (b) SEM images of aligned fibrous scaffolds (scale bar: 1 µm); (c) the quantitative distribution of fibre diameters; (d) The orientation direction distribution of the scaffold fibres; (e) the SEM image of the neurons on the aligned scaffold (scale bar: 200 µm); (f) the SEM image of the neurons on the aligned scaffold (scale bar: 20 µm); and (g) the directional histogram of cells on the aligned scaffolds obtained by ImageJ®.